Mativ Holdings, Inc. (MATV) SEC Filings & Earnings Calls
EquiReason read 19 Mativ Holdings, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-08-06 — Q2 2026 results: revenue up 1.2% YoY, gross margin improved, net income turned positive..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 665.6M
- P/E TTM
- —
- Dividend yield
- 3.3%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
6 Aug 202610-QQ2 2026 results: revenue up 1.2% YoY, gross margin improved, net income turned positive.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $532M | +1% y/y |
| Gross profit · Q2-2026 | $113M | +9% y/y |
| Net income (loss) · Q2-2026 | $4M | |
| Diluted income (loss) per share · Q2-2026 | $0.06 | |
| Cash provided by operations · Q2-2026 | $68M | +18% y/y |
| Capital spending · Q2-2026 | $8M | -14% y/y |
Risks flagged
Tariff cost uncertainty
“The net impact of IEEPA tariff refund claims submitted and accepted by U.S. CBP as of June 30, 2026 was not significant.” · word for word
Volume decline in FAM segment
“FAM segment net sales decreased primarily due to lower volume/mix driven by filtration & netting and the impact from an exited facility.” · word for word
5 Aug 20268-K · 2.02Mativ reported Q2 2026 sales of $531.8M (+1.2% YoY), GAAP net income of $3.6M vs loss of $9.5M, adjusted EBITDA $75.0M (+12% YoY), margin 14.1% (+130bps YoY), free cash flow $60.4M (+24% YoY). Strongest quarter since merger.earningsopen
Figures in the filing · each found in the filing text
| Sales · Q2-2026 | $532M | +1% y/y |
| GAAP net income · Q2-2026 | $4M | -138% y/y |
| Adjusted EBITDA · Q2-2026 | $75M | +12% y/y |
| Adjusted EBITDA margin · Q2-2026 | 14.1% | |
| Free cash flow · Q2-2026 | $60M | +24% y/y |
| Cash from operating activities · Q2-2026 | $68M | +18% y/y |
| Total debt · Q2-2026 | $975M | |
| FAM segment sales · Filtration & Advanced Materials · Q2-2026 | $202M | -1% y/y |
| FAM segment adjusted EBITDA margin · Filtration & Advanced Materials · Q2-2026 | 17.6% | |
| SAS segment sales · Sustainable & Adhesive Solutions · Q2-2026 | $330M | +3% y/y |
Risks flagged
FAM segment organic sales decline of 0.1% indicates volume/mix weakness in filtration and netting
“FAM segment sales ... down 0.1% on an organic basis ... reflecting lower volume/mix in our Filtration & Netting business, including the impact from an exited facility” · word for word
High effective tax rate of 47% due to geographical earnings mix and valuation allowance on losses in certain jurisdictions
“Tax rate was 47% for the three months ended June 30, 2026, primarily driven by our geographical earnings mix and our inability to benefit from losses in certain jurisdictions that have a full valuation allowance” · word for word
7 May 202610-QNet sales $480M (-1% y/y); Gross profit $85M (+17% y/y); Net loss $-12Mopen
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $480M | -1% y/y |
| Gross profit · Q1-2026 | $85M | +17% y/y |
| Net loss · Q1-2026 | $-12M | |
| Operating cash flow · Q1-2026 | $1M | |
| Free cash flow · Q1-2026 | $-7M | |
| Capital spending · Q1-2026 | $8M | -40% y/y |
| Total debt · Q1-2026 | $1.04B | |
| Cash and cash equivalents · Q1-2026 | $82M |
Risks flagged
High leverage
“Total debt $1,035.8M vs equity $472.3M, net debt to EBITDA covenant of 5.50x”
Interest rate exposure
“Weighted average effective interest rate 7.50%, with $175M floating rate revolver”
Foreign exchange risk
“Foreign currency translation loss of $8.8M in OCI”
6 May 20268-K · 2.02Sales $480M (-1% y/y); GAAP loss $-12M; Adjusted income $4Mearningsopen
Figures in the filing · each found in the filing text
| Sales · Q1-2026 | $480M | -1% y/y |
| GAAP loss · Q1-2026 | $-12M | |
| Adjusted income · Q1-2026 | $4M | |
| Adjusted EBITDA · Q1-2026 | $48M | +28% y/y |
| Adjusted EBITDA margin · Q1-2026 | 9.9% | |
| Adjusted EPS · Q1-2026 | $0.06 | |
| Free cash flow · Q1-2026 | $-7M | |
| Cash from operating activities · Q1-2026 | $1M | |
| Total debt · Q1-2026 | $1.04B | |
| Cash and cash equivalents · Q1-2026 | $82M |
Risks flagged
Sales decline in SAS segment due to lower volume/mix; negative free cash flow despite improvement.
“SAS sales down 2.0% YoY; free cash flow -$7.4M.”
6 May 20268-K · 5.02, 5.07Reported the departure of a director or principal officer (CEO/CFO change); submitted matters to a vote of security holdersopen
Risks flagged
Increased share authorization may lead to dilution of existing shareholders.
“Approval of amendment to increase shares under equity plan.”
6 Apr 20268-K · 1.01Mativ amended credit agreement to refinance and restructure debt, increasing total facilities to ~$894.9M with tighter covenants and higher interest margins, reflecting financial stress.open
Figures in the filing · each found in the filing text
| Revolving Credit Facility · Q1-2026 | $305M | |
| Term A Loan Commitments · Q1-2026 | $90M | |
| Term B Loan Commitments · Q1-2026 | $500M | |
| Aggregate Principal Amount · Q1-2026 | $895M |
Risks flagged
Increased financial leverage and covenant step-ups may pressure operations if EBITDA declines.
“Net Debt to EBITDA ratio covenant steps down from 5.00x to 4.00x; interest coverage steps up to 3.00x.”
Refinancing eliminates delayed draw term loan, reducing future flexibility.
“Amendment eliminates the delayed draw term loan facility.”
2 Apr 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen
Risks flagged
Loss of a key executive could disrupt operations or strategy.
“Group President resignation without named successor or transition plan.”
25 Mar 20268-K · 7.01TTM Revenue $2.00B; TTM Adjusted EBITDA $225Mopen
Figures in the filing · each found in the filing text
| TTM Revenue · Q4-2025 | $2.00B | |
| TTM Adjusted EBITDA · Q4-2025 | $225M |
17 Mar 2026DEF 14AProxy statement for 2026 annual meeting, including say on pay vote and approval of equity plan amendment.open
Figures in the filing · each found in the filing text
| Free Cash Flow · FY2025 | $94M | |
| Net Debt Reduction · FY2025 | $60M | |
| Cost Savings · FY2025 | $20M | |
| Capital Expenditures · FY2026 | $45M | |
| EBITDA Delivered · FY2025 | $225M | |
| Revenue · FY2025 | $1.98B | |
| Free Cash Flow as a Percent of Net Sales · FY2025 | 4.6% | |
| Return on Invested Capital · FY2025 | 4.9% | |
| Net Income · FY2025 | $-337M | |
| Total Shareholder Return · FY2025 | 38.4% |
Risks flagged
Management transition risk
“During 2025, the Company experienced a number of changes in its senior leadership.” · word for word
Leverage risk
“allowed us to reduce our net debt by over $60 million, resulting in significant progress in reducing our leverage.” · word for word
Net income loss
“Net Income ($ Millions) ... 2025 (337.4)”
26 Feb 202610-KGoodwill impairment charge $412M; Cost savings from restructuring $20M; Net debt reduction since merger 45; Guidance: Targeting additional $15-20M cost savings by end of 2026open
Figures in the filing · each found in the filing text
| Goodwill impairment charge · Q1-2025 | $412M | |
| Cost savings from restructuring · FY2025 | $20M | |
| Net debt reduction since merger · point_in_time | 45.0% |
Guidance
Targeting additional $15-20M cost savings by end of 2026
No revenue or earnings guidance provided. Cost savings targets are outlined: $15-20M additional by end of 2026. Goodwill impairment signals financial stress, but debt reduction and restructuring progress are positives.
Risks flagged
Goodwill Impairment Risk
“during the first quarter of 2025, primarily in response to a sustained decline in the Company's share price, an interim quantitative goodwill impairment test was performed, which resulted in a goodwill impairment charge of $411.9 million.” · word for word
Tariff Exposure
“The implementation of tariffs or border taxes has increased our cost of goods sold, which in turn impacted our pricing and our financial performance.” · word for word
Raw Material Cost Volatility
“The cost of wood pulp...and some resins...are highly cyclical and can be more volatile than general consumer or producer inflationary changes.”
Chinese Competition
“We are starting to see increased competition for some of our FAM products from companies in China, which, we believe, may have lower operating costs than us, resulting in a potential price advantage for such companies.” · word for word
18 Feb 20268-K · 2.02Sales $463M (+1% y/y); Adjusted EBITDA $54M (+19% y/y); Adjusted EBITDA margin 11.6earningsopen
Figures in the filing · each found in the filing text
| Sales · Q4-2025 | $463M | +1% y/y |
| Adjusted EBITDA · Q4-2025 | $54M | +19% y/y |
| Adjusted EBITDA margin · Q4-2025 | 11.6% | |
| GAAP EPS · Q4-2025 | $1.80 | |
| Adjusted EPS · Q4-2025 | $0.15 | |
| Free cash flow · Q4-2025 | $8M | |
| Full Year Sales · FY2025 | $1.99B | +0% y/y |
| Full Year Adjusted EBITDA · FY2025 | $225M | +3% y/y |
| Full Year Free cash flow · FY2025 | $94M | +139% y/y |
| FAM segment sales · Filtration & Advanced Materials · Q4-2025 | $177M | +6% y/y |
Risks flagged
Anemic market demand and dynamic trade/macro policies
“We continue navigating an environment of anemic market demand and dynamic trade and macro-economic policies” · word for word
6 Nov 202510-QMativ reported Q3 2025 net sales of $513.7M (+3.0% YoY), gross margin improvement to 19.3%, and net loss narrowed to $3.2M from $20.8M in the prior year quarter.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2025 | $514M | +3% y/y |
| Gross profit · Q3-2025 | $99M | +6% y/y |
| Net loss · Q3-2025 | $-3M | |
| Diluted loss per share · Q3-2025 | $-0.06 | |
| Cash provided by operations · Q3-2025 | $73M | +94% y/y |
| Capital spending · Q3-2025 | $6M | -50% y/y |
| FAM segment net sales · Filtration & Advanced Materials · Q3-2025 | $198M | +5% y/y |
| SAS segment net sales · Sustainable & Adhesive Solutions · Q3-2025 | $315M | +2% y/y |
| Total debt · 2025-09-30 | $1.03B | |
| Cash and cash equivalents · 2025-09-30 | $97M |
Risks flagged
Tariff uncertainty and cost impact
“Increased tariffs by the United States have led and may continue to lead to the imposition of retaliatory tariffs by foreign governments.” · word for word
Goodwill impairment risk
“In the FAM segment, operating loss was $376.0 million during the nine months ended September 30, 2025 reflecting a $435.7 million decrease, compared to operating profit of $59.7 million in the prior year period primarily due to the $411.9 million goodwill impairment during the first quarter of 2025” · word for word
High leverage
“Per the terms of the Company's amended credit agreement, net leverage was 4.2x at the end of the third quarter, versus a current maximum covenant ratio of 5.50x.” · word for word
5 Nov 20258-K · 2.02Sales $514M (+3% y/y); Adjusted EBITDA $67M (+10% y/y); Adjusted EBITDA margin 13earningsopen
Figures in the filing · each found in the filing text
| Sales · Q3-2025 | $514M | +3% y/y |
| Adjusted EBITDA · Q3-2025 | $67M | +10% y/y |
| Adjusted EBITDA margin · Q3-2025 | 13.0% | |
| GAAP EPS · Q3-2025 | $-0.06 | |
| Adjusted EPS · Q3-2025 | $0.39 | |
| Free cash flow · Q3-2025 | $67M | +179% y/y |
| FAM segment sales · Filtration & Advanced Materials · Q3-2025 | $198M | +5% y/y |
| SAS segment sales · Sustainable & Adhesive Solutions · Q3-2025 | $315M | +2% y/y |
| Total debt · Q3-2025 | $1.03B | |
| Cash and cash equivalents · Q3-2025 | $97M |
Mativ Holdings, Inc. — questions
- What did Mativ Holdings, Inc. file recently?
- 19 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-06 — Q2 2026 results: revenue up 1.2% YoY, gross margin improved, net income turned positive.
Every figure on this page comes from Mativ Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.